跳至主要内容
临床试验/IRCT20220907055908N1
IRCT20220907055908N1招募中3 期

Investigating the anti-inflammatory effect of colchicine in patients undergoing coronary artery bypass graft (CABG) in Semnan kosar hospital in 1401: A randomized clinical trial

Semnan University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 80 years(—)
性别
All

入选标准

  • patients over 30 years old and under 80 years old
  • patients needing CABG surgery
  • Informed consent

排除标准

  • patients should have contraindications to colchicine or atorvastatin
  • patients with a history of severe liver diseases
  • patients who have creatinine clearance less than 50.
  • patients with a history of atrial fibrillation or atrial flutter or 2nd and 3rd-degree heart block
  • patients with autoimmune diseases or a history of taking immunosuppressive drugs in the last 1 month
  • patients with heart failure Ejection Fraction < 35%
  • patients with a history of muscle conflicts
  • patients of taking fibrate drugs
  • patients with leukopenia or active infection
  • patients with acute coronary syndrome

研究者

发起方
Semnan University of Medical Sciences

相似试验